Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients

  • The PLOS ONE Staff
  • Article
  • Metrics
  • Comments
  • Media Coverage

The affiliation for the last author is incorrect. Takanori Shibata is not affiliated with #6 but with #2 Showa University, School of Medicine, Division of Nephrology, Department of Medicine, Tokyo, Japan. The publisher apologizes for the error.

Reference

  1. 1. Honda H, Michihata T, Shishido K, Takahashi K, Takahashi G, Hosaka N, et al. (2017) High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients. PLoS ONE 12(5): e0176984. pmid:28475601

Citation: The PLOS ONE Staff (2017) Correction: High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients. PLoS ONE 12(6): e0179139. https://doi.org/10.1371/journal.pone.0179139

Published: June 1, 2017

Copyright: © 2017 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.